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Abstract
Under normal conditions the immune system has limited access to the brain; however, during toxoplasmic encephalitis (TE),
large numbers of T cells and APCs accumulate within this site. A combination of real time imaging, transgenic reporter mice,
and recombinant parasites allowed a comprehensive analysis of CD11c
+ cells during TE. These studies reveal that the CNS
CD11c
+ cells consist of a mixture of microglia and dendritic cells (DCs) with distinct behavior associated with their ability to
interact with parasites or effector T cells. The CNS DCs upregulated several chemokine receptors during TE, but none of
these individual receptors tested was required for migration of DCs into the brain. However, this process was pertussis toxin
sensitive and dependent on the integrin LFA-1, suggesting that the synergistic effect of signaling through multiple
chemokine receptors, possibly leading to changes in the affinity of LFA-1, is involved in the recruitment/retention of DCs to
the CNS and thus provides new insights into how the immune system accesses this unique site.
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Introduction
Resistance to the parasite Toxoplasma gondii is characterized by
an acute phase of infection associated with activation of innate
immune cells such as neutrophils, dendritic cells (DCs), and
macrophages that produce IL-12, which promotes NK and T cell
production of IFN-c [1,2] These events lead to the early control of
parasite replication and the transition into the chronic phase of
infection where the parasite persists as tissue cysts, most notably
within the CNS [3–5]. While the immune privileged nature of the
brain may contribute to the ability of T. gondii to persist, several
studies have highlighted that the inflamed brain (during CNS
infections and during EAE) is an immunologically active site where
activated T cells are constantly surveying their environment [6–9].
CD4
+ and CD8
+ T cells contribute to the local control of T. gondii
in the CNS but much less is known about the contribution of
various APC populations within the brain to T cell mediated
resistance to this infection [10–12].
DCs are regarded as the most potent APCs responsible for
initiation of immune responses and have a critical role in
promoting resistance to T. gondii [13–16]. Highly activated DCs
are also present within the brain during TE [17,18] and similar
accumulation of DCs within the CNS has been reported in other
models of neuro-inflammation [19,20]. While the DCs that are
found in the CNS under normal conditions (primarily in the
meninges and choroid plexus) have been proposed to be
tolerogenic [21–23], the DCs present during neuro-inflammation
have been ascribed numerous functions. During EAE, DCs
isolated at the onset of disease were found to prime inflammatory
T cells, while the DCs isolated at the peak of disease were
relatively poor APCs and supported the development of regulatory
T cells [19,24,25]. Other studies indicate that CNS DCs can
function as efficient APCs and may serve to amplify intra-cerebral
T cell responses [17,26]. Regardless, during TE, the behavior and
function of DCs within the CNS remains unclear.
Multiple mechanisms have been proposed to account for the
accumulation of DCs within the CNS during neuroinflammation.
Some studies indicate that microglia can differentiate into DCs
during inflammation [18,27], while others have proposed that
DCs in the brain arise from peripheral haematopoietic cells
[19,28]. During TE, the precise origin of the CNS DCs is unclear:
whether they are a local population that is constantly renewed or
they are recruited from the peripheral circulation has not been
addressed. Furthermore, while recent studies have highlighted the
molecular signals required for the migration of DCs within
secondary lymphoid compartments [29], much less is known about
the migratory patterns of DCs into peripheral sites such as the
inflamed brain and the signals required for their retention within
these sites.
To better understand the phenotype and function of the CNS
resident DCs during TE, a combination of imaging techniques,
transgenicreportermice(CD11c
YFPand OT1
GFP) and recombinant
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were used. These studies revealed that during TE, the CD11c
+ cells
form an extensive network consisting of microglia and DCs. In vitro
antigen presentation studies and real time imaging suggest that the
CNS resident CD11c
+ cells can function as efficient APCs. These
studies also showed that CD11c
+ cells isolated from the brain
expressed higher levels of the chemokine receptors CCR7, CCR5,
CXCR3, CX3CR1 compared to their splenic counterparts,
suggesting a possible role for these receptors in the migration and
retention of these cells within the brain. However, the loss of any
individual chemokine receptor (tested) did not affect the ability of
DCs to migrate into the brain, in an adoptive transfer model.
Nevertheless, this process was pertussis toxin sensitive (indicating a
role for Gai coupled chemokine receptors) and LFA-1 dependent.
These studies point towards a model in which the synergistic effect
of signaling through multiple chemokine receptors, potentially leads
to a change in the affinity of the integrin LFA-1 on the surface of
DCs and controls their migration and retention within the CNS
during TE.
Results
Characterization of the CD11c
+ cells in the brain during
chronic infection
TE is associated with increased numbers of CD11c
+ cells within
the brain [17], however little is known about the subset composition,
phenotype and behavior of these cells in vivo. Therefore, the APC
populations within the brain during TE were characterized by flow-
cytometry. In uninfected mice there were minimal numbers of
immune cells present in the brain, and microglia (CD45
int CD11b
+
cells)werethedominantimmunepopulation(Figure1Atop).During
TE, in addition to the microglia, there is an increase in the number
of APCs (CD3
2CD19
2NK1.1
2) of haematopoietic origin (CD45
hi)
(Figure 1A bottom). These include macrophages (CD11c
2CD11b
+)
and DCs (CD11c
+). The myeloid DCs (CD11b
+CD11c
+)f o r mt h e
largest subset (about 80–90% of the CD11c
+ fraction), followed by
the lymphoid (CD8
+CD11c
+) and plasmacytoid (PDCA
+ B220
+)
subsets (each constitute ,5% of the CD11c
+population). Allofthese
populations were activated based on their expression of high levels of
markers such as MHC I, MHC II, CD80 and CD86 (Figure S1).
To directly visualize CD11c
+ cells within the brain during TE,
CD11c
YFP mice were used. In these reporters, few YFP
+ cells were
identified within the brain parenchyma in naı ¨ve mice (Figure 1B).
During TE, consistent with the flow-cytometric data, there was an
increase in the number of CD11c
YFP cells (Figure 1B), which
formed an extensive network within the brain parenchyma.
Analysis of YFP
+ cells revealed that they consisted of DCs
(CD11c
hiCD45
hi) and microglia (CD11b
hiCD45
int), consistent
with previous reports that microglia can up-regulate CD11c
during inflammation [30–32] (Figure 1C).
In situ imaging by multiphoton microscopy using the CD11c
YFP
mice revealed two distinct morphological phenotypes: amoeboid
and dendriform cells (Figure 1D). In the naive brain the CD11c
+
cells exhibited an amoeboid structure whereas during infection
there was an increased proportion of dendriform CD11c
+ cells
(Figure 1E). In comparison to the cells seen in the naı ¨ve brain,
during TE there was marked increase in the average surface area
of the CD11c
+ cells, (Figure 1F right) and an increased proportion
of CD11c
+ cells that displayed a vacuolated phenotype (Figure 1F
left). Using fluorescent parasites (Pru
OVA Tomato), infected cells
could be identified (Figure 1G), however a large proportion of the
vacuolated cells were not associated with parasites. The presence
of vacuoles in the absence of identifiable parasites has been noted
previously both with DCs in the lymph node and astrocytes in the
brain during T. gondii infection [8,14] and is indicative of an
activated phenotype. The proportion of CD11c
+ cells (DCs and
microglia) that were infected with parasites was less than 10%
(Figure 1H). CD11c
+ cells were also observed associated with
parasite cysts within the CNS (Figure 1I, Video S1), with about
60–70% of the cysts intimately associated with CD11c
+ cells
(Figure 1J, Video S2). Together, these studies show that TE results
in a significant increase in CD11c
+ cells composed of a mixed
population of activated microglia and dendritic cells, which exhibit
distinct morphologies and behaviors.
DC-T cell interactions during TE
Since CNS resident DCs can have immuno-stimulatory or
tolerogenic properties, studies were performed to assess whether
the CD11c
+ cells present in the brain during TE can present
antigen to T cells. Naı ¨ve OT1
GFP T cells were adoptively
transferred into CD11c
YFP mice followed by infection with Pru
or Pru
ova parasites, to determine whether antigen specific T cells
interacted with DCs in vivo. In CD11c
YFP mice infected with
parental strain of the parasite (Pru) there was minimal infiltration
of OT1
GFP cells into the brain (Figure 2A), but during infection
with Pru
OVA, significant numbers of T cells were present within
the brain (Figure 2A, Video S3). The OT1
GFP cells interacted with
the CD11c
YFP cells and made sustained contacts (highlighted with
red circles) or short-lived contacts (highlighted with blue circles) as
seen in the representative time series (Figure 2B). Further analysis
revealed that the T cells showed a range in their motilities (average
velocity ,10 mm/min) with highly motile cells, cells that paused
briefly and cells that were rounded up and stationary for much of
the imaging period (10–15 minutes). In contrast, the CD11c
+ cells
showed minimal motility (average ,2 mm/min) (Figure 2C left).
The duration of the interactions between the T cells and DCs was
calculated and the frequency of T cells exhibiting different contact
durations was determined (Figure 2D). Majority of the T-DC
interactions observed were between uninfected DCs and T cells,
which is consistent with the data that only a small percentage of
CD11c
+ cells are infected. (Figure 1H). Analysis of the interaction
times revealed two populations: a larger population (P1) of motile
Author Summary
Toxoplasmic encephalitis (TE), caused by the protozoan
parasite Toxoplasma gondii, can be potentially life threat-
ening especially in immuno-compromised individuals.
Immune cells including dendritic cells have been shown
to accumulate in the brain during chronic toxoplasmosis;
however, little is known about their function, their
behavior in vivo, and the mechanisms by which they
migrate into the brain. In the present studies, we utilize a
combination of real time imaging, transgenic reporter
mice, and recombinant parasites to reveal the distinct
behavior and morphologies of dendritic cells within the
brain and their ability to interact with parasites and
effector T cells during TE. The CNS DCs were also found to
exhibit a unique chemokine receptor expression pattern
during infection, and the migration of DCs into the brain
was mediated through a pertussis toxin (which blocks
signaling downstream of several chemokine receptors)
sensitive process and dependent on the integrin LFA-1.
There is currently a poor understanding of the events that
lead to DC recruitment to the CNS during inflammation in
general, and our studies provide new insights into the
mechanisms by which antigen-presenting cells gain access
to the brain during infection.
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+ cells for shorter durations (less
than 4 minutes) and a smaller subset (P2) of more rounded T cells
that were engaged in prolonged interactions with DCs (Figure 2D).
The prolonged interactions were however not restricted to the
infected DCs and could thus be indicative of antigen presentation
or target cell lysis.
Since CNS resident DCs have been proposed to generate
tolerogenic T cell responses [21,33,34], the ability of DCs present
in the CNS during TE to prime naı ¨ve antigen specific T cells was
evaluated. CD11c
+ cells were isolated from either the brain or
spleens of infected mice, incubated with ovalbumin and co-
cultured with naı ¨ve CFSE labeled OT1 T cells. The OT1 T cells
that were primed by the CD11c
+ cells from the brain proliferated
(as indicated by dilution of CFSE), albeit at a slightly lower rate
compared to the T cells that were primed by splenic DCs
(Figure 2E). The CD8
+ T cells primed under the two different
conditions (splenic or brain CD11c
+ cells) exhibited a similar
pattern of cytokine secretion and produced IFN-c but not IL-10
(Figure 2F). Control experiments were also performed to compare
DCs isolated from the spleens of naive and infected mice and these
studies did not reveal any significant differences in their ability to
stimulate OT1 T cells (data not shown). Together, these data
indicate that the CD11c
+ cells found during chronic toxoplasmosis
are capable of processing and presenting antigen to CD8
+ T cells
and do not skew naı ¨ve T cells to a tolerogenic phenotype.
Chemokine receptor profile of CNS resident CD11c
+ cells
The source of the CD11c
+ cells found within the CNS during
TE is not clear and several alternate mechanisms have been
proposed for their recruitment and retention during neuro-
inflammation. In order to identify whether CD11c
+ cells present
in the brain during TE were derived from haematopoietic
precursors, bone marrow cells (depleted of mature T cells) from
CD11c
YFP transgenic mice were used to reconstitute lethally
irradiated WT recipient mice. In such CD11c
YFP-.WT chimeras
very few CD11c
YFP cells (bone marrow derived) could be found
within the brain in the naı ¨ve mice (Figure 3A). However, during
chronic TE, significant accumulation of CD11c
YFP cells was
observed within the brain (Figure 3A). Radiation chimeras were
also generated using congenic mice, which differed in the CD45
allotype (CD45.1-.CD45.2) to distinguish donor and recipient
cells. These studies revealed that greater than 95% of the DCs and
approximately 70-75% of the microglia found within the brain
during TE were of donor origin (Figure 3B) indicating that the
microglia and DCs present within the brain during chronic TE are
largely bone marrow derived.
In order to understand the factors that influence the recruitment
of DCs to the brain during TE, the levels of chemokine receptor
mRNA and surface expression on CD11c
+ cells within the brain
during infection were compared to those in the periphery. The
number of CD11c
+ cells that could be isolated and purified from
an uninfected brain was minimal and precluded analysis.
Nevertheless, there were significant differences in the levels of
chemokine receptor mRNA expression between CD11c
+ cells
isolated from the brains of infected mice compared to splenic
populations. While chemokine receptors such as XCR1 and
CXCR5 were not altered, others such as CCR1 were lower on the
CNS resident DCs compared to splenic DCs (Figure 3C).
However, CD11c
+ cells from the brain expressed increased levels
of transcripts for CCR7, CXCR3, CCR5 and CX3CR1 (Figure 3D
left) and flow cytometric analysis showed that both microglia and
DCs upregulated these chemokine receptors. In contrast, CXCR4
was expressed only on the DCs and not on microglia during
infection. These studies identify multiple chemokine receptors that
represent candidates to mediate DC migration and retention
within the brain.
Adoptive transfer system for DC trafficking
To understand the factors that control the recruitment and
retention of DCs during TE, an adoptive transfer system was
developed to quantify the migration of DCs into this site. Initial
experiments using either immature or mature bone marrow DCs
showed limited migration of this DC subset into the CNS (data not
shown). As an alternate approach, CD11c
+ cells that were
expanded in vivo with FLT3L expressing tumor cells and
subsequently purified using CD11c
+ MACS beads, were used as
a source of DCs [35]. Morphologically these cells resemble DCs
(Figure S2A) and flow cytometric analysis of these cells showed
that they are CD11c
+, lineage negative (CD3
2CD19
2NK1.1
2),
MHC class II
+ and the proportion of various DC subsets is
comparable to those found in naı ¨ve spleens (CD11b
+CD11c
+,
CD11b
2CD8
+) as seen previously [35,36]. The in vivo expanded
DCs showed a chemokine receptor pattern typical of mature
splenic DCs and express CCR7, CXCR3, CCR5 and CX3CR1
(Figure S2A).
To determine if these DCs could traffic into the brain during
chronic TE, they were transferred iv into naı ¨ve or infected mice
and were tracked by 1) using congenic markers (CD45.1) 2)
loading DCs with NIR
2polymersomes or 3) labeling DCs with
dyes such as TRITC (Figure S2B). In the first example, using the
congenic marker CD45.1, transferred DCs could be tracked
within the brain of infected recipients by flow cytometry 18–
24 hours post transfer (Figure 4A). Analysis of various markers
including CD11c, CD11b, MHCII and Ly6C indicated that the
DCs that migrated to the brain were representative of the
transferred population and not significantly different from those
found in the other compartments such as the blood, lymph nodes
and spleen (Figure 4A). In a different approach to track the
Figure 1. Phenotypic and behavioral characterization of CD11c
+ cells within the brain. A) The various APC populations found within
CD3
2CD19
2NK1.1
2 fraction of BMNCs isolated from naive (top) or infected (bottom) mice. The first set of plots shows the relative proportions of
microglia (CD45
int CD11b
+) and the other APCs of haematopoietic origin (CD45
hi). The CD45
hi population consists primarily of DCs (CD45
hiCD11c
+)
and CD11b
+ cells (macrophages/monocytes). The DC fraction was further subseted by staining for CD8, CD11b, PDCA and B220 to identify the
myeloid (CD11b
+CD11c
+), lymphoid (CD11c
+CD8
+) and plasmacytoid (CD11c
+CD11b
2B220
+PDCA
+) DCs. B)3 0mm z stacks of brain slices from naive
and infected CD11c
YFP mice (D 21-post infection) imaged by 2-photon microscopy. C) The expression of CD11c on the microglia (CD45
intCD11b
+)
from naive (top) or infected (bottom) mice. D) The two prominent types of morphologies (amoeboid and dendriform) observed amongst the
CD11c
YFP cells in the brain. E) The relative proportion of the amoeboid and dendriform cells (expressed as a percentage of the total CD11c
YFP cells)
analyzed from 30 mm z stacks of brain slices from naive and infected CD11c
YFP mice. F) Left: Average number of vacuolated cells from multiple z
stacks of brain slices from naive and infected CD11c
YFP mice. Cells with greater than 2 vacuoles were included in the analysis. Right: The average
surface area of CD11c
YFP cells that was calculated from multiple z stacks (30 mm) of brain slices from naive and infected mice. G) CD11c
YFP cells seen
in association with a reactivating cyst (top) and tachyzoite infected CD11c
YFP cells (bottom). H) The percentage of CD11c
+ cells that were either
uninfected (open bars) or infected (black bars) amongst BMNC isolated from Pru
OVA tomato infected mice. I) CD11c
YFP cells in close association with
parasite cysts (top panel). A cyst (showing individual bradyzoites) wrapped in YFP
+ cells (bottom). J) The percentage of cysts observed across multiple
imaging regions, that were either associated with or not associated with CD11c
YFP cells.
doi:10.1371/journal.ppat.1002246.g001
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+ cells are efficient antigen presenting cells. A) Representative z stacks (30 mm) of brain slices from CD11c
YFP
mice that received OT1
GFP cells and were infected with Pru (left) or Pru
OVA (right) 3 weeks prior. B) Representative time series showing short term
(blue circles) and sustained (red circles) interactions between OT1
GFP and CD11c
YFP cells. C) The average migration velocities of OT1
GFP T cells and
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(containing near infrared dyes) were transferred into naı ¨ve or
infected mice and 18–24 hours later near infrared imaging of
whole organs was performed (Figure 4B). In naı ¨ve mice, fewer
DCs migrated to the brain and these cells were primarily within
the spleen and lymph nodes. In contrast, in infected mice
significant numbers of polymersome loaded DCs could be detected
within the brain (Figure 4B). DCs labeled with TRITC could
similarly be tracked within the brain using multi photon
microscopy and the transferred DCs could be co-imaged with
OT1
GFP cells (Figure 4C, Video S4) and endogenous CD11c
YFP
cells (Figure 4D, Video S5). Morphologically the transferred DCs
exhibited lower average surface area and had a slightly higher
velocity compared to endogenous DCs (Figure 4E, Video S5).
However, these cells exhibited a surface phenotype typical of DCs
(CD11c
+, CD11b
+, MHC class II
+, Ly6C
2) as seen in Figure 4A.
In other experiments transferred monocytes were similarly shown
to traffic to the brain but exhibited a distinct phenotype (CD11c
2,
Ly6C
+, CD11b
+, CD115
+) compared to the DCs (Figure S3).
These approaches validate a model in which the entry of mature
DCs from the circulation to the brain during chronic infection can
be quantified and these populations can be visualized.
The migration of DCs into the brain is pertussis toxin
sensitive
To determine whether the migration of DCs into the brain was
dependent on chemokine receptor mediated signaling, the effect of
pertussis toxin (PTX), an inhibitor of Gai coupled chemokine
receptors, was tested. In these studies, DCs were pretreated with
PTX in vitro for three hours, washed and transferred into naive or
T. gondii infected mice (day 21 post infection), and analyzed 18–
24 hours post-transfer. Flow cytometric analysis revealed that
significantly lower numbers of PTX treated DCs accumulated
within the brains of infected mice compared to control DCs
(Figure 5A). The numbers of DCs in the spleen was not altered by
the PTX treatment, however their migration into the lymph nodes
was also PTX sensitive. The peripheral blood showed an increase
in the number of DCs in the PTX treated group, suggesting that
the cells that are not recruited in the tissue compartments remain
in the blood. Similar studies using polymersome loaded DCs and
whole animal imaging revealed that the accumulation of PTX
treated DCs was much lower than untreated DCs within the
infected brain (Figure 5B). These data demonstrate that the
accumulation of adoptively transferred DCs in the brain during
TE is a pertussis toxin sensitive process.
Chemokine receptors involved in DC trafficking
Since the migration of transferred DCs into the brain was
blocked by PTX, the role of individual chemokine receptors in DC
migration was tested. Since CCR7 was expressed at high levels on
brain DCs, the expression of the chemokine CCL21 (ligand for
CCR7) was elevated during infection (Figure 6A), and CCR7 on
the brain DCs was functional in in vitro chemotaxis studies
(Figure 6B), this receptor was first targeted. To directly test the role
of CCR7 in the trafficking of DCs into the brain, the transfer
system described above was modified to allow co-transfer of equal
numbers of CFSE labeled WT and TRITC labeled CCR7
2/2
DCs. Real time imaging studies indicated that both WT and
CCR7
2/2 DCs could be found in equivalent frequencies within
the brain parenchyma (Figure 6C top) and there was no significant
difference in their average migration velocity (Figure 6C bottom).
To track these cell populations by flow cytometry CD45.2
+ WT
and CD45.2
+ TRITC
+ CCR7
2/2 were transferred into infected
CD45.1
+ mice thus enabling identification of the WT and
CCR7
2/2 DCs within the same recipients (Figure 6D). However,
the absence of CCR7 did not significantly affect the accumulation
of DCs in the brain (Figure 6E). The role of other chemokine
receptors that were up regulated on the CNS DCs including
CCR5, CXCR3, CX3CR1, CCR2 and CCR6 were examined
using the respective chemokine receptor deficient mice in this
competitive transfer model. In these studies the absence of any one
of these receptors did not affect the ability of DCs to migrate into
the infected brain (Figure 6E), suggesting the cooperative action of
multiple chemokines in this process or the role of an as yet
untested chemokine receptor/s.
Migration of DCs into the brain is LFA-1 dependent
Signaling downstream of the Gai coupled receptors has been
shown to increase the affinity of many integrins particularly LFA-1
and VLA-4, for their respective ligands [37–40]. Since our studies
showed an effect of pertussis toxin treatment on migration of DCs
into the brain, the role of integrins in this process was examined.
Previous studies have highlighted the importance of VLA-4 in the
migration of T cells into the inflamed CNS [9,41] however the role
of integrins in the migration of DCs to this site is less clear.
Flowcytometric analysis of BMNCs revealed that several integrins
including LFA-1 (aLb2) and VLA-4 (a4b1) were expressed by the
microglia and DCs, but there was minimal expression of CD103
(aEb7) by the CD11c
+ cells from the brain (Figure 7A). Of the
various integrins tested LFA-1 was expressed at the highest level by
the DCs. While DCs in the brain or spleen did not change their
expression of LFA-1 during infection, the microglia showed an
upregulation of LFA-1. To test whether high levels of LFA-1 seen
on the surface of the DCs had a functional role in their migration
to the CNS, the high affinity form of LFA-1 was blocked using
monoclonal antibodies in the adoptive transfer model with DCs.
DCs were pretreated in culture for 3 hours with anti-CD11a
antibody (or control antibody), or alternatively, the mice were
treated with the blocking antibodies prior to DC transfer. Both
pre-treatment of DCs with anti CD11a antibody and in vivo
antibody administration, resulted in an inhibition in the ability of
the DCs to migrate to the brain (Figure 7B: Group 1 versus Group
2 and 3). Mice that received anti CD11a treated DCs and were
additionally treated in vivo with the blocking antibody displayed the
most pronounced inhibition (Group 1 versus Group 4). Blocking
VLA-4 had minimal effect on the migration of DCs into the brain
using this adoptive transfer system (Figure S4). Together these data
show that the migration of adoptively transferred DCs into the
CNS during TE is an LFA-1 dependent process.
Discussion
Dendritic cells have been identified within the CNS during
various parasitic, bacterial, viral infections and autoimmune
CD11c
YFP obtained by manual tracking using Volocity. D) The frequency of OT1
GFP cells interacting with CD11c
YFP cells and the duration of these
interactions is shown on the y-axis. The imaging sessions typically lasted between 12–15 minutes. E) CFSE dilution profile of naı ¨ve OT1 cells that were
co-cultured (3 days) with CD11c
+ cells purified from either spleen or brain (of chronically infected mice). F) The ability of the proliferated cells to
produce the cytokines IFN-c and IL-10, during re-stimulation (6 hours) in vitro in the presence of brefeldin-A, with/without antigenic peptide
(SIINFEKL).
doi:10.1371/journal.ppat.1002246.g002
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+ cells express a distinct chemokine receptor expression profile. A) Brain slices from naı ¨ve (left) or infected
(right) CD11c
YFP-.WT bone marrow chimeras imaged by 2 photon microscopy B) The proportion of donor (CD45.2) and host cells (CD45.1) amongst
the DC and microglial compartment of the brain from infected CD45.2-.CD45.1 radiation bone marrow chimeras. C) The expression of the
chemokine receptors XCR1, CCR1 and CXCR5 on CD11c
+ cells purified from the brain or spleen of infected mice measured by real time PCR,
normalized to the expression of endogenous house-keeping gene HPRT and expressed as fold increase over control (splenic DCs from naive mice). D)
Left: The relative expression of chemokine receptors CCR7, CXCR3, CCR5, CX3CR1 and CXCR4 measured by real time PCR from CD11c
+ cells isolated
from the brain and spleens of naı ¨ve and infected mice. Right: Flow cytometric analysis of the same chemokine receptors on DCs and microglia from
naive (blue) or infected mice (red) compared to the isotype control (grey).
doi:10.1371/journal.ppat.1002246.g003
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clear consensus about the function of CNS resident DCs, their
origin, behavior and migratory patterns. Thus, several studies have
highlighted that CNS DCs are inhibitory for adaptive immune
responses [21,22,33], while others have indicated that they are
capable of inducing inflammatory T cell responses [18,19,44]. The
present studies indicate that the CD11c
+ cells isolated from the
brain during TE are capable of processing and presenting antigen
to naı ¨ve T cells in vitro to generate functional T cell responses. The
in vivo imaging studies show that while the majority of the T cells
interacted transiently with the CD11c
+ cells, a smaller subset of T
cells engaged in prolonged interactions, could be identified which
is consistent with the T cell-APC contacts observed recently by
Robey and colleagues in the brain [45]. Our studies also revealed
that only a small proportion of the DCs that were interacting with
the T cells were actively infected and the prolonged interactions
were not restricted to the infected cells, which suggests the
involvement of both direct and cross presentation pathways in the
activation of the CD8
+ T cells. These data are in support of a
model in which DCs and microglia provide local tonic signals to
maintain the effector functions of the intracerebral T cells. In
addition, the imaging studies have revealed the close association
between parasite cysts and CD11c
+ cells. Neurons are considered
to be the major cell type that houses cysts [46], and based on
immunohistology the regions around the cyst were thought to be
largely quiescent. However, the current studies reveal that the
microglia and DCs are intimately associated with the parasite cysts
with their dendrites and cell bodies tightly wrapped around the
cysts, suggesting possible innate sensing of this stage of the parasite.
Several alternate models have been proposed for the origin of
DCs within the brain. Our studies using radiation bone marrow
chimeras shows that the majority of the CD11c
+ cells (.95%) that
expand in the CNS during TE are bone marrow derived. This
could represent constant recruitment of DCs from the periphery
during infection or a local expansion of bone marrow precursor
cells that initially seeded the CNS. Recent studies by Merad and
colleagues has shown that the microglia are derived from primitive
myeloid progenitors and not from post natal haematopoietic
precursors [47,48]. However several other studies indicate that
damage and inflammation within the CNS can result in greater
proportions of haematopoietic precursor derived microglia
[49,50]. In the present studies, the majority of the microglia
Figure 4. Adoptively transferred DCs migrate from the periphery into the inflamed brain. A) Transferred DCs (CD45.1) recovered from the
brain, spleen, lymph nodes and peripheral blood of recipient animals 18–24 hours later. The expression of CD11c, CD11b, MHCII, and Ly6C on the
CD45.1
+ fraction (transferred population) is shown in the panels on the right. B) Whole organ imaging using a Licor Odyssey imager of the brain,
spleen and cervical lymph nodes from naı ¨ve or infected mice that received DCs loaded with near infrared dye labeled polymersomes. C) Snapshot
showing TRITC labeled DCs and OT1
GFP T cells in a brain slice from a Pru
OVA infected mouse. D) Snapshot showing transferred DCs (red), OT1
GFP T and
endogenous CD11c
YFP cells in the infected brain. E) The average migration velocity of transferred DCs (red triangles) and endogenous CD11c
YFP cells
(yellow triangles).
doi:10.1371/journal.ppat.1002246.g004
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CD45
int microglia are derived from the CD45
hi precursors,
however whether the down-regulation of CD45 occurs within an
intermediate precursor population or on the cells that are resident
within the brain for prolonged periods, is not completely clear.
The adoptive transfer studies suggest that migration of DCs
from peripheral circulation is one of the mechanisms that
contribute to the accumulation of the CD11c
+ cells within the
brain during TE. Migration of monocytes and their conversion to
DCs is another proposed mechanism that contributes to the DC
populations within the inflamed CNS and our preliminary
studies using purified monocytes indicate that they can migrate
to the brain during TE (Figure S3). While conversion of the
monocytes to DCs was not observed immediately (18-24 hours)
after transfer, whether this happens over time, remains to be
tested.
Several chemokines and their receptors, including CCR7 and its
ligands (CCL19 and CCL21) and the CCL3/CCR5 receptor
ligand system have been implicated in the migration of DCs into
the CNS, primarily based on EAE studies and clinical data from
MS patients [51-53]. During chronic TE, several chemokines
(CCL19, CCL21, CCL3, CCL5, CXCL9, CXCL10) are up
regulated within the CNS [54,55]. In our studies the adoptively
transferred DCs migrated to the brain through a pertussis toxin
sensitive mechanism, suggesting that the signaling though the Gai
coupled chemokine receptors was involved in this process. Since
Figure 5. Migration of adoptively transferred DCs into the brain is a pertussis toxin sensitive process. A) Total numbers of PTX treated
or control DCs (derived from flow-cytometric analysis of the transferred population) within the spleen, brain, lymph node or blood (PBMC) of
recipient mice 18–24 h after transfer. B) Whole organ near infrared imaging of brain and spleen from infected mice that either received control or PTX
treated DCs. Naı ¨ve mice that received control DCs is also included. The DCs were loaded with polymersomes containing near infrared dyes to track
them.
doi:10.1371/journal.ppat.1002246.g005
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ability of these DCs to migrate to the brain, we conclude that this
process is possibly mediated through the synergistic effect of
signaling events downstream of multiple receptors [56]. A
downstream effect of signaling through Gai coupled receptors
results in changes in the conformation of integrins from low to
high affinity forms and has been shown to control the migration of
immune cells into lymph nodes [37–40]. Recently the integrin
VLA-4 has been shown to be involved in the recruitment of
immature DCs into the CNS during EAE [34]. In our model, the
migration of DCs into the brain was found to be dependent on
LFA-1, but not VLA-4. Thus, our current studies are consistent
with a model in which signaling events downstream of multiple
Gai coupled chemokine receptors results in changes in the affinity
of LFA-1 on the surface of the DCs and influences their
recruitment into the inflamed CNS [37–40,56].
Until recently the role of integrins within the CNS, was largely
focused on the effects of VLA-4 in the migration of T cells and this
forms the basis for the clinical development of a monoclonal
antibody (Natalizumab) against a4 integrin to treat MS [57,58].
However, a subset of patients treated with Natalizumab developed
progressive multifocal leukoencepahalopathy, due to reactivation
of latent JC polyoma virus infection [59]. Interestingly another
monoclonal antibody (Efalizumab) directed against LFA-1, which
was developed for the treatment of Psoriasis resulted in a similar
complication [60]. These clinical studies indicate the importance
of LFA-1 in addition to VLA-4 in the migration of immune
effectors into the CNS. The identification of LFA-1 as an
Figure 6. Migration of transferred DCs to the brain is not dependent on CCR7, CCR5, CCR2, CXCR3, CX3CR1 or CCR6. A)
Representative immuno-histochemical staining for CCL21, CD11c and DAPI on 6 mm sections of a chronically infected brain. B) The proportion of
different cellular subsets (DCs, CD4
+ and CD8
+ T cells) from BMNCs, isolated from infected brains that migrate in response to graded doses of the
chemokine CCL21 in an in vitro chemotaxis assay. C) Top: Snapshot of a 30 mm z stack from an infected brain imaged using 2P microscopy showing
WT and CCR7
2/2 DCs. Analysis of several such images did not show any significant differences in the localization of the WT and CCR7
2/2 DCs.
Bottom: The average velocity of the WT and CCR7
2/2 DCs. D) Left: Pre-transfer donor population (CD45.2
+) that consists of an equal mixture of WT
(TRITC
2) and CCR7
2/2 (TRITC
+) cells. Right: Donor cells recovered from the spleen of CD45.1
+ recipient mice where the two different DC populations
can be identified. E) The total numbers of CCR7
2/2, CCR5
2/2 CCR2
2/2, CXCR3
2/2,C X 3CR1
2/2, CCR6
2/2 recovered from the spleen and brains in a
competitive DC transfer system. The differences between the WT and the various CCR deficient DCs that accumulated in the brain and spleen were
not significant (p.0.05 in all cases as measured by student’s t test).
doi:10.1371/journal.ppat.1002246.g006
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CNS bears significance for the design of therapeutic targets to
control CNS inflammation.
Materials and Methods
Mice
WT C57BL/6 mice and CD45.1 congenic mice were purchased
from Jackson laboratories (Bar Harbor, ME). OT1
GFP mice were
obtained by crossing DPE-GFP transgenic mice to OT1 TCR
transgenicmice,asdescribedpreviously[14].CD11C
YFPtransgenic
mice were obtained from Michel C Nussenzweig [61]. CCR2
2/2,,
CX3CR1
2/2, CCR7
2/2, CCR5
2/2, CCR6
2/2 were purchased
from Jackson laboratories. The CXCR3
2/2 mice were obtained
from Andrew Luster (MGH, Boston MA). The various transgenic
mice colonies were maintained in a specific pathogen-free (SPF)
facility in the Department of Pathobiology at the University of
Pennsylvania in conformance with institutional guidelines for
animal care.
Ethics statement
All animal studies were carried out in compliance with the
guidelines of the Institutional Animal Care and Use Committee
(IACUC) of the University of Pennsylvania and in accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
animal protocol was approved by the Institutional Animal Care
and Use Committee (IACUC) of the University of Pennsylvania,
Philadelphia PA (Multiple project assurance # A3079-01).
Parasites
The Prugniaud strain of Toxoplasma gondii was maintained as
tachyzoites by serial passage through HFF monolayers. Transgenic
parasites engineered to express cytoplasmic tdTomato and to
secrete ovalbumin protein into the parasitophorous vacuole
(described previously (46)) were maintained by antibiotic selection
in the cultures. In general, mice were infected ip with the various
strains of T. gondii at a dose of 10
4 parasites per mouse.
Figure 7. Migration of DCs into the brain is LFA-1 dependent. A) Flowcytometric analysis showing expression of LFA-1, VLA-4 and CD103 on
the microglia, brain DCs and splenic DCs of naı ¨ve (blue) or infected mice (red) compared to the isotype controls (grey). B) The percentage inhibition
in the accumulation of DCs within the brain or spleen during anti LFA-1 treatment (in vitro and in vivo) compared to control conditions. The number
of control DCs that were tracked within the brain or spleen of the control mice (Group 1) was normalized to a 100% and the numbers of transferred
DCs in the other groups were expressed as a percentage of this control. The treatment conditions for the various groups, is indicated in the legend
box within the Figure.
doi:10.1371/journal.ppat.1002246.g007
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1) T cell transfers. T cells were enriched from lymphocytes
isolated from the spleen and pooled peripheral lymph nodes of
OT1
GFP mice using the mouse T cell enrichment columns (R&D
systems, Minneapolis, MN) as described previously [14]. 2610
6
purified OT1
GFP cells were injected into recipient mice iv. The
recipient mice were infected with parasites 24-hours later and the
immune responses in the brain were typically analyzed on day 21-
post infection.
2) Adoptive transfer of DCs. DCs were enriched in vivo by
injecting WT or chemokine deficient mice, subcutaneously with
3610
6 FLT3L secreting b16 tumor cells. 10–14 days later CD11c
+
DCs were enriched from the spleens by positive selection using
CD11c (N418) micro-beads (Miltenyi Biotec). The CDllc
+ cells
were labeled with the fluorescent dye TRITC for tracking them
microscopically and by flow cytometry. Alternatively, congenic
markers (CD45.1 or CD45.2) were used to track them in the
recipients. 5610
6 DCs were transferred iv into chronically infected
mice D21.
LFA-1/VLA-4 blocking
To block LFA-1 or VLA-4 in vitro, the purified DCs were treated
with 30 mg/ml of anti CD11a antibody (Clone M-17/4, BioXcell,
West Lebanon, NH) or anti VLA-4 (Clone PS/2, BioXcell, West
Lebanon, NH) for 3 hours prior to transfer. For in vivo treatments
chronically infected mice were treated with two doses of the anti
LFA-1 or anti VLA-4 (150 mg each) antibody, one dose prior to
transfer of DCs (26 hours) and one dose at the time of DC
transfer. The control antibody used in these cases was Rat IgG.
The mice were sacrificed 18–24 hours after transfer of DCs.
NIR polymersome loading and whole organ imaging
Purified splenic DCs were loaded with Tat-functionalized near-
infrared emissive polymersomes, as described previously [62]. The
various organs (brain, spleen and lymph nodes) were isolated from
the animals 18–24 hours later and fluorescence imaging was
performed using an Odyssey infrared imaging system (LI-COR
Biosciences, Lincoln, NE).
Preparation of tissue for live imaging
Mice were sacrificed by CO2 asphyxiation and the brain was
removedwithminimaldamagetothetissue.Ahorizontalsliceofthe
brain (between 1.5–2 mm thick) was cut as described previously [8]
and placed in a temperature controlled imaging chamber and the
tissue was held in place using a nylon mesh and an organ holder
(Warner Instruments, Hamden CT). The chamber was constantly
perfused with warm (37uC) oxygenated (95% O2/5%CO2) media
(RPMI+10% FBS) and the temperature was maintained at 37uC
using heating elements and a temperature control probe.
2-photon microscopy
Ex vivo imaging was done using a Leica SP5 2 photon microscope
equipped with a picosecond laser (Coherent Chameleon; 720 nm–
980 nm) and tunable internal detectors that allow simultaneous
detection of emissions of different wavelengths and second harmonic
signals (SHG). EGFP, YFP and tdTomato were excited using laser
light of 920 nm. Typically, z stacks of a series of x-y planes with a
total thickness of 30 mm and step size of 6 mm were captured. The
LAS-AF software (Leica) was used for image acquisition. For 4D
data sets, images were captured every 25–30 seconds and the
imaging depths are as specified in the different images.
Image analysis
Volocity software (PerkinElmer, Waltham MA) was used to
convert the three dimensional image stacks into time series.
Single cell tracking was done by a combination of manual
tracking and automated tracking and mean migratory velocities
were calculated as described previously. For measurement of T
cell–DC interactions, the duration of contacts of all the T cells
observed in a given filed of view were calculated for the entire
imaging period (typically lasting 12–15 minutes). Cellular
contacts were determined manually as a lack of space between
the interacting cells and the data obtained from an average of 3–5
imaging regions from 3 individual mice per group were used to
obtain the frequency of T cells with different durations of contacts
with DCs.
RNA isolation and real time PCR for chemokines
RNA was isolated from CD11c
+ cells purified using CD11c
MACs micro-beads (Miltenyi Biotech, Auburn, CA) from the
brain mononuclear cells or splenocytes isolated from chronically
infected mice. TRIzol (Invitrogen) and DNase treated total RNA
was reverse transcribed using Superscript II (Invitrogen, Carlsbad
CA) using standard protocols. Quantitative PCR was performed
with customized primer sets for CCR7, CCR5, CX3CR1,
CXCR4, XCR1, CXCR5 and HPRT (QIAGEN, Valencia CA)
using SYBR green PCR assay system and an ABI 7500 instrument
(Applied Biosystems, Carlsbad, CA). The values for the various
chemokine receptors were normalized to HPRT and displayed as
fold induction over naı ¨ve splenic DC controls.
Isolation of cells from various tissues
Brain mononuclear cells were isolated using a standard protocol
described previously [8]. Briefly, mice were perfused with cold
PBS, the brain was removed, diced, passed through an 18-gauge
needle and digested with Collagenase/Dispase and DNAse for 45
minutes at 37uC. The cell suspension was then washed and
fractionated on a 30%–60% percoll gradient (Pharmacia) for 20
minutes. The cells in the interface consisted of mononuclear cells,
which were washed prior to experiments. Peripheral blood was
obtained from mice by cardiac puncture, and the RBCs were
separated using a Lympholyte-M gradient (Cedarlane, ON,
Canada). Lymphocytes were isolated from spleens and cervical
lymph nodes by mechanical homogenization followed by lysis of
RBCs (for spleens) using lysis buffer (0.846% NH4Cl).
Flow-cytometric analysis
Freshly isolated cells were stained with the antibodies purchased
from eBioscience (San Diego, CA) or BD Biosciences (San Jose,
CA). For intracellular staining the cells were stimulated ex-vivo for
5 hours in complete media with Brefeldin A, either in the presence
or absence of SIINFEKL peptide (1 mg/ml). Following surface
staining, the cells were fixed with 4% PFA for 10 minutes at room
temperature. The cells were permeabilized using 0.3% saponin in
staining buffer. The stained samples were run on a FACSCanto
(BD, San Jose, CA) and results were analyzed using FlowJo
software (TreeStar Inc., Ashland, OR).
Statistical analysis
Statistical significance of differences between groups of mice was
tested using the student’s t test or ANOVA/ Kruskal-Wallis test for
multiple groups. In all the cases, p,0.05 was considered
significant.
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Figure S1 The DCs within the brain show an activated
phenotype following infection. The expression of MHC I,
MHC II and CD80 on the total CD11c
+ DC population (extreme
left) and the various subsets of DCs (CD11b
+, CD8
+,
CD11b
2CD8
2 and pDCs) from the BMNCs isolated from naı ¨ve
(grey-filled) or infected (black) mice.
(TIF)
Figure S2 Phenotype of DCs used for adoptive transfer.
A) DIC image and flow-cytometric characterization of the DCs
used for the adoptive transfer. B) DCs tracked by various
techniques 1) loading with polymersomes containing near infrared
dyes (left) 2) TRITC labeled (middle) 3) or by flowcytometry (right)
using congenic markers (CD45.1) and polymersomes.
(TIF)
Figure S3 Monocyte transfer. The adoptively transferred
monocytes (CD45.1) recovered from the brain and other tissues
18–24 hours post transfer. The expression of the markers CD11b,
Ly6C, CD115 and CD11c on the recovered populations is shown
in the right panels. The Monocytes used for the transfers were
isolated from the bone marrow and purified a multistep protocol
involving depletion of Ly6G
+ cells followed by enrichment of
CD11b
+ cells.
(TIF)
Figure S4 VLA-4 is not involved in the migration of DCs
into the brain. The total numbers of control or anti VLA-4
treated DCs recovered from the brain and spleen of recipient mice
that were either treated in vivo with anti VLA-4 or control
antibody.
(TIF)
Video S1 Interaction between DCs and parasite cysts. A
representative time-lapse sequence (30 mm stack) showing the
CD11c
YFP cells within the brain scanning the surface of Pru
OVA
tomato cysts (day 21 post infection). OT1
GFP T cells that were
transferred prior to infection can also be seen within these regions.
Second harmonic structures can be visualized in blue.
(MOV)
Video S2 Close association between CD11c
YFP cells and
parasite cysts. 3D rendering of a 30 mm z stack showing the
intimate association between a CD11c
YFP cell and a parasite cyst
(individual bradyzoites can be seen) within the brain of a Pru
OVA
Tomato infected mice.
(MOV)
Video S3 Interactions between CD11c
YFP cells and T
cells within the brain during TE. 3D time-lapse sequence of
30 mm stacks of live brain slices from a CD11c
YFP transgenic
mouse that was adoptively transferred with OT1
GFP cells and
infected with Pru
OVA parasites. The movie shows OT1
GFP cells
making contacts with CD11c
YFP cells, majority of which are brief.
However, a smaller population of OT1
GFP cells that indulge in
long-term interactions with CD11c
YFP can also be seen.
(MOV)
Video S4 Migration of transferred DCs into the brain.
Maximum projection time-lapse sequence of 30 mm stacks
showing TRITC labeled transferred DCs (24 hours after transfer
of DCs) within the brain of mice that had received OT1
GFP T cells
and were infected with Pru
OVA 3 weeks earlier.
(MOV)
Video S5 Co-localization of transferred and endogenous
DCs within the brain. Maximum projection time-lapse
sequence showing transferred TRITC labeled DCs (24 hours post
transfer) within the brain of a CD11c
YFP transgenic mouse that
had received OT1
GFP T cells and were infected with Pru
OVA 3
weeks earlier. The transferred DCs, T cells and endogenous
CD11c
+ cells can be visualized within the same regions of the
brain.
(MOV)
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